Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726921 · ClinicalTrials.gov registry record
Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 189
- Enrollment target
NCT00726921: Completed study, sponsored by University of Nebraska.
NCT00726921 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 189 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00726921 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 189 participants
- Enrollment target
Study Summary
This study investigates hypothesizes that the combination of dobutamine stress echocardiography with dobutamine stress echocardiography with real time perfusion myocardial contrast echocardiography and coronary computed tomography is a better modality for detecting coronary artery disease in end-stage renal disease patients than coronary angiography, and in predicting patient outcomes. Demonstrating this would lead to increased use of DSE with RTCE and coronary CT at kidney transplant centers throughout the nation, leading to improved anatomical and functional detection of CAD without the need for further invasive procedures.
Primary Outcome
To examine the ability of dobutamine stress echocardiography with real time perfusion (DSE with RTCE) and coronary computed tomographic angiography (cCTA) to detect anatomically significant coronary artery disease (CAD) as defined by invasive angiography in end-stage renal disease (ESRD) patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2008-08-25 |
| Est. Completion | 2012-12-21 |
What the finished NCT00726921 record still lists
NCT00726921 is an observational study that tracks outcomes without assigning an intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00726921 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00726921 about?
NCT00726921 is a clinical study titled "Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients". This study investigates hypothesizes that the combination of dobutamine stress echocardiography with dobutamine stress echocardiography with real time perfusion myocardial contrast echocardiography and coronary computed tomography is a better modality for detecting coronary artery disease in end-sta...
What is the current status of trial NCT00726921?
This trial is currently completed. The enrollment target is 189 participants. The study started on 2008-08-25. Estimated completion is 2012-12-21.
Who is sponsoring clinical trial NCT00726921?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI